UPDATE 1-Merck's sales miss as Keytruda, diabetes drugs lag estimates

Feb 2 (Reuters) - Merck & Co Inc's quarterly revenue narrowly missed Wall Street expectations, hurt by lower-than-expected sales of its key immuno-oncology drug, Keytruda, and its diabetes medicines. [Source]

Publication Date: Thursday, 2 February 2017 at 14:37:23

Origin: reuters.com

Category: marketsNews

Topics: diabetes, Keytruda, sales, medicines, immuno-oncology, by lower-than-expected, expectations, Street, missed, revenue narrowly, quarterly, Inc's, Merck, (Reuters), estimates, drugs, 1-Merck's, UPDATE

Source: http://feeds.reuters.com/~r/news/usmarkets/~3/l0bof7GsBkc/merck-co-results-idUSL4N1FN2MW

WRAPUP 2-U.S. labor market tightening, productivity still weak

[ reuters.com ] marketsNews, Thursday, 2 February 2017 at 18:34:20

UPDATE 2-ConocoPhillips loss smaller than expected on higher oil price

[ reuters.com ] marketsNews, Thursday, 2 February 2017 at 18:34:15

Irish tax revenues rise in January as VAT receipts surge

[ reuters.com ] marketsNews, Thursday, 2 February 2017 at 18:30:06

Peru posts $1 bln trade surplus in Dec, $1.7 bln in 2016-cenbank

[ reuters.com ] marketsNews, Thursday, 2 February 2017 at 18:29:09

CEE MARKETS-Protests hit Romanian auction, Czechs keep guidance on crown

[ reuters.com ] marketsNews, Thursday, 2 February 2017 at 16:43:23

Analyzed News